This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Goldman JM and Druker BJ (2001) Chronic myeloid leukemia: current treatment options. Blood 98: 2039–2042
Gale RP et al. (1998) Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group. Blood 91: 1810–1819
Ohnishi K et al. (2004) Multicenter prospective study of interferon alpha versus allogeneic stem cell transplantation for patients with new diagnoses of chronic myelogenous leukemia. Int J Hematol 79: 345–353
Druker BJ et al. (2006) Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355: 2408–2417
Schmitz N et al. (2006) Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 108: 4288–4290
Simonsson B, on behalf of the ISG (2005) Beneficial effects of cytogenetic and molecular response on long-term outcome in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib (IM): update from the IRIS Study [abstract]. ASH Annual Meeting Abstracts 106: 166a
Acknowledgements
The synopsis was written by Eleftheria Rosmaraki, Assistant Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
T Hughes has received honoraria for lectures, and is recipient of clinical research support from BMS and Novartis. Dr Hughes is a patent holder for Novartis.
Rights and permissions
About this article
Cite this article
Hughes, T. Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia?. Nat Rev Clin Oncol 5, 14–15 (2008). https://doi.org/10.1038/ncponc0983
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0983